Milvia Zambetti
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects
Most-Cited Works
- → Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort(2010)1,254 cited
- → Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up(1995)1,046 cited
- → Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer(2005)618 cited
- → Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.(1998)567 cited
- → Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort(2014)488 cited
- → Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer(1985)291 cited
- → 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study(2005)251 cited
- → Outcome of Different Timings of Radiotherapy in Implant-Based Breast Reconstructions(2011)240 cited
- → Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study(2014)235 cited
- → Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer(2009)216 cited